Category Archives: Eczema

Derived from the Greek language, the word eczema translates to something like to boil. And anyone who has atopic dermatitisthe most common form of eczemacan probably see why. The symptoms often shows up as red, itchy rashes on your arms and legs, and can sometimes cause open sores or resemble scaly skin. Although its possible to develop atopic dermatitis for the first time as an adult, the majority of people experience it shortly after they were born, perhaps as young as two months old. Most people outgrow it in their early teens, but it can come back later in life, says Whitney High, MD, an associate professor of dermatology and pathology at the University of Colorado School of Medicine, in Denver. For some people, atopic dermatitis continues through into adulthood and never lets up. The condition itself is likely hereditary, and usually runs in the same circles as allergic rhinitis and asthma. Families that have one child with eczema often have another child with asthma or even a third child with seasonal rhinitis or hay fever, he says. To limit your odds of experiencing a flare up, here are nine things to avoid. A long soak in the tub might … Continue reading →

eMaxHealth The top 5 natural remedies that will help you heal eczema ... eMaxHealth Eczema is a common form of dermatitis ( skin inflammation), which typically appears as an itchy rash on the arms and behind the knees. It can be debilitating, ... and more » Excerpt from: The top 5 natural remedies that will help you heal eczema ... - eMaxHealth … Continue reading →

Boston Business Journal Sanofi Genzyme hit with patent lawsuit over new eczema drug Boston Business Journal Immunex Corp., a subsidiary of Amgen (Nasdaq: AMGN), filed a complaint in Los Angeles federal court on April 5 claiming that an eczema drug developed by Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals (Nasdaq: REGN) infringes a patent related to ... Amgen, already on PCSK9 offense, slaps Sanofi, Regeneron with Dupixent patent suitFiercePharma all 2 news articles » Read this article: Sanofi Genzyme hit with patent lawsuit over new eczema drug - Boston Business Journal … Continue reading →

The drug was found to have anti-inflammatory properties that can beat the itch caused by the conditions IT is already being tested totreat chronic pain, nausea and anorexia but now cannabis could be used to treat painful skin conditions too. The drug contains anti-inflammatory properties that could help ease the pain of eczema, psoriasis and dermatitis, experts have discovered. Alamy And, even more promising for those who suffer with the conditions, it could prove successful at getting rid of the dreaded itch that comes with them. Researchers fromUniversity of Colorado Anschutz Medical Campus found the active ingredient in cannabis, calledtetrahydrocannabinol (THC), successful in reducing inflammation and swelling in mice. Tests also showed thatmice with melanoma saw their tumour growth slowed significantly when injected with THC but researchers warnedit was not yet a potential treatment for the disease. The possible new treatment comes in the form of a cream that has anti-inflammatory properties from the cannabinoids. Eight out of 21 patients who applied the cream twice a day for three weeks were completely free of itching afterwards Robert Dellavalle, lead author and associate professor of dermatology at the university, said: Perhaps the most promising role for cannabinoids is in the treatment … Continue reading →

April 14, 2017 4:55 PM By Dr. Maria Simbra PITTSBURGH (KDKA) Theres a new treatment for eczema, thats offering relief to patients. Eucrisa was approved by the Food and Drug Administration in December. It works on the overactive part of the immune system in eczema, a protein called phosphodiesterase. Before, only a pill could quiet this enzyme. This new formulation can be absorbed through the skin. Unlike steroids, it can be used in sensitive areas where the skin may already be thin, such as the face, eye lids, and groin. And its approved for use in kids as young as two. In studies where it was compared to a plain moisturizer, the rash cleared for only one in five in the comparison group, but one in three using Eucrisa. Researchers did find one minor side effect. Join The Conversation On The KDKA Facebook Page Stay Up To Date, Follow KDKA On Twitter About four percent of people who used it had pain when they put the medication on, Dermatologist Dr. Brian Horvath with Horvath Dermatology says. But he says thats not unexpected for people with thin or broken skin. However, he says Eucrisa may be best for treating what comes … Continue reading →

Eczema affects a large proportion of children and adolescents in the United States. New research investigates whether silk clothing improves health outcomes for children with eczema. Eczema - also known as atopic dermatitis - is a chronic dermatological disease that causes the skin to itch and become very dry. Although the condition is not contagious, people with eczema may be vulnerable to other viral and bacterial skin diseases. Atopic dermatitis affects approximately 30 percent of the U.S. population, according to the National Institutes of Health (NIH). Children and adolescents seem to be particularly at risk of eczema, the NIH report. Clothing seems to play an important role in the management of the disease. Patients are routinely advised to wear cotton or smooth fabrics and avoid materials such as wool, which may worsen the itching. Furthermore, in countries such as the United Kingdom, specialist silk clothing is available on prescription for people with eczema. As a result, a team of researchers from the University of Nottingham in the U.K. - led by Kim Thomas and colleagues - set out to investigate the benefits of wearing silk garments for children with eczema. The study was published in the journal PLOS Medicine. Thomas … Continue reading →

FDA approved a new ointment for eczema that can help manage symptoms Miami Herald Eucrista, also called crisaborole, is an FDA-approved ointment used to treat mild to moderate eczema in adults and children ages 2 and older. It is not a steroid and does not cause skin thinning and other side effects that occur with prolonged steroid use. See the rest here: FDA approved a new ointment for eczema that can help manage symptoms - Miami Herald … Continue reading →

TRENTON, N.J. U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema. The Food and Drug Administration on Tuesday approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs. In three studies of the drug including a total of 2,119 participants, one-third to two-thirds achieved clear or nearly clear skin. About 4 in 10 had itching decrease sharply, bringing better sleep and reducing anxiety and depression. Dupixent will have an initial list price of $37,000 a year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York, which developed the drug. Eczema treatments generally have been limited to topical medications, steroid creams, moisturizers and ultraviolet light, plus antihistamines to relieve itching. Those work fairly well for mild eczema, but not the severe form, also called atopic dermatitis. Its also the most common form. Wire reports Eczema often begins in young children, and most grow out of it, said Dr. Lisa Beck, a dermatology professor at the University of Rochester Medical Center in Rochester, New York. But for other patients, the condition persists throughout adulthood, tormenting patients with relentless itching that … Continue reading →

A California woman died in March after being given an IV of turmeric, the San Diego County Medical Examiner confirmed Thursday. NBC 7 reported that Jade Erick, 30, went to see a naturopathic practitioner for treatment of her eczema on March 10. She was taken to Scripps Memorial Hospital Encinitas, where she reacted badly to the IV. Dr. Kim Kelly was reportedly administering a 250 mL infusion of turmeric, an Indian spice that has several uses in natural healing. Erick became unresponsive after just 5 mL of the infusion. Dr. Kelly immediately called emergency services and gave Erick CPR while he waited for them to arrive. The report said that woman was sent to the ICU when she arrived at the hospital. The autopsy report read that Erick was diagnosed with severe anoxic brain injury secondary to cardiopulmonary arrest, most likely due to turmeric infusion. Erick died 6 days after she was admitted to the hospital. The medical examiners report indicated that Erick had several food allergies to soy protein, lactose and gluten, as well as hypothyroidism and pre-diabetes. Her mother reportedly told authorities that her daughter never had an infusion of turmeric before, but she had taken the spice … Continue reading →

The U.S Food and Drug Administration has just approved Dupixent, a new treatment option for people with moderate-to-severe eczema. Dupixent works as an injection under the skin, andwas developed for patients whose condition can not becontrolled by topical treatments. However, it also gives patients who would typically use a topical treatmenta break from applying creamsto the skin multiple times per day. Eczema is a condition when patches of skin become inflamed, itchy, red, cracked and rough. Most people outgrow the condition as children, but some continue to endure symptoms into adulthood. The causes of eczema are unknown, however it is believed to develop due to both genetic factors such as having parents with atopic diseases and environmental factors such as irritants, allergens, microbes, extreme temperatures, food, stress and hormones. Dupixent was approved by the FDA after going through 3 clinical trials that included roughly 2,100 adults with moderate-to-severe eczema, whose symptoms could not be controlled by topical treatments. After 16 weeks, those who received Dupixent had clearer skin and less itching than those who received the placebo. The most common side effects of the drug included injection site reactions, cold sores in the mouth and lips, and eye/eyelid inflammation. The … Continue reading →